Challenges and opportunities for overcoming dog use in agrochemical evaluation and registration.


Journal

ALTEX
ISSN: 1868-8551
Titre abrégé: ALTEX
Pays: Germany
ID NLM: 100953980

Informations de publication

Date de publication:
2023
Historique:
received: 15 02 2023
accepted: 01 03 2023
medline: 21 7 2023
entrez: 8 3 2023
pubmed: 9 3 2023
Statut: ppublish

Résumé

Progress in developing new tools, assays, and approaches to assess human hazard and health risk provides an opportunity to re-evaluate the necessity of dog studies for the safety evaluation of agrochemicals. A workshop was held where partic­ipants discussed the strengths and limitations of past use of dogs for pesticide evaluations and registrations. Opportunities were identified to support alternative approaches to answer human safety questions without performing the required 90-day dog study. Development of a decision tree for determining when the dog study might not be necessary to inform pesticide safety and risk assessment was proposed. Such a process will require global regulatory authority participation to lead to its acceptance. The identification of unique effects in dogs that are not identified in rodents will need further evaluation and determination of their relevance to humans. The establishment of in vitro and in silico approaches that can provide critical data on relative species sensitivity and human relevance will be an important tool to advance the decision process. Promising novel tools including in vitro comparative metabolism studies, in silico models, and high-throughput assays able to identify metabolites and mechanisms of action leading to development of adverse outcome pathways will need further development. To replace or eliminate the 90-day dog study, a collaborative, multidisciplinary, international effort that transcends organi­zations and regulatory agencies will be needed in order to develop guidance on when the study would not be necessary for human safety and risk assessment.

Identifiants

pubmed: 36888967
doi: 10.14573/altex.2302151
doi:

Substances chimiques

Agrochemicals 0
Pesticides 0

Types de publication

Editorial

Langues

eng

Sous-ensembles de citation

IM

Pagination

534-540

Auteurs

Patricia L Bishop (PL)

Humane Society of the United States, Washington, DC, USA

Susy Brescia (S)

Health and Safety Executive, Liverpool, UK

Rachel Brunner (R)

formerly in United States Environmental Protection Agency, Office of Chemical Safety and Pollution Prevention, Office of Pesticide Programs, Washington, DC, USA and currently in United States Environmental Protection Agency, Office of Chemical Safety and Pollution Prevention, Office of Pollution Prevention and Toxics, Washington, DC, USA

Warren Casey (W)

National Institute of Environmental Health Services (NIEHS), Research Triangle Park, NC, USA

Kathleen Conlee-Griffin (K)

Humane Society of the United States, Washington, DC, USA

Richard A Currie (RA)

Syngenta, Berkshire, UK

Jeanne Domoradzki (J)

Corteva Agriscience, Indianapolis, IN, USA

Michelle Embry (M)

Health and Environmental Sciences Institute (HESI), Washington, DC, USA

Maria Ines Harris (MI)

Instituto Harris, São Paulo, Brazil

Thomas Hartung (T)

Johns Hopkins University, Bloomberg School of Public Health and Whiting School of Engineering, Center for Alternatives to Animal Testing (CAAT), Baltimore, MD, USA
University of Konstanz, CAAT-Europe, Konstanz, Germany

Gina M Hilton (GM)

PETA Science Consortium International, Stuttgart, Germany

Barry Hooberman (B)

US Department of Health and Human Services, Washington, DC, USA

Brandall Ingle (B)

United States Environmental Protection Agency (EPA), Washington, DC, USA

Kyung-Jin Jang (KJ)

Outer Biosciences, Palo Alto, CA, USA

Lewis Kinter (L)

Green Lawn Professional Scientific Consulting, DE, USA

Caroline Krall (C)

Johns Hopkins University School of Medicine, Baltimore, MD, USA

Joseph Leedale (J)

Syngenta, Berkshire, UK

Anna Lowit (A)

formerly in United States Environmental Protection Agency, Office of Chemical Safety and Pollution Prevention, Office of Pesticide Programs, Washington, DC, USA and currently in United States Environmental Protection Agency, Office of Chemical Safety and Pollution Prevention, Office of Pollution Prevention and Toxics, Washington, DC, USA

Jyotigna Mehta (J)

ADAMA, Reading, UK

Elizabeth Mendez (E)

United States Environmental Protection Agency (EPA), Washington, DC, USA

Bob Mingoia (B)

Corteva Agriscience, Indianapolis, IN, USA

Eliana Munarriz (E)

Universidad de Buenos Aires, Department of Biological Chemistry, Ciudad Autónoma de Buenos Aires, Argentina

Lynea Murphy (L)

Corteva Agriscience, Indianapolis, IN, USA

Angela Myer (A)

United States Environmental Protection Agency (EPA), Washington, DC, USA

Antoniana Ottoni (A)

Humane Society of the United States, Washington, DC, USA

Martina Panzarea (M)

European Food Safety Authority, Parma, Italy

Monique Perron (M)

United States Environmental Protection Agency (EPA), Washington, DC, USA

Juan Pina (J)

Atanor S.C.A., Munro, Argentina

Deborah Ramsingh (D)

Health Canada, Ottawa, ON, Canada

Fiona Sewell (F)

National Centre for the Replacement Refinement & Reduction of Animals in Research, London, United Kingdom

Jennifer Swanson (J)

independent writer, USA

Yu-Mei Tan (YM)

United States Environmental Protection Agency (EPA), Washington, DC, USA

Andrea Terron (A)

European Food Safety Authority, Parma, Italy

Maria A Trainer (MA)

Australian Pesticides and Veterinary Medicines Authority, Armidale, NSW, Australia

Marize Campos Valadares (MC)

Laboratory of Education and Research in In Vitro Toxicology (Tox In), Faculty of Pharmacy, Universidade Federal de Goiás, Goiânia, GO, Brazil

Steven Webb (S)

Syngenta, Berkshire, UK

Elizabeth Webb (E)

Bayer Crop Science, Chesterfield, MO, USA

Catherine Willett (C)

Humane Society International, Washington, DC, USA

Douglas C Wolf (DC)

Syngenta Crop Protection, Greensboro, NC, USA

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH